NASDAQ:CELU
Celularity Inc. Stock News
$3.02
-0.0500 (-1.63%)
At Close: Apr 26, 2024
FLORHAM PARK, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic cell therapies and advanced
Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit
09:15am, Thursday, 14'th Mar 2024
Presentation Will Discuss Cellular Immunotherapy's Potential Role in Treating Chronic Conditions and Extending People's Lives Presentation Will Discuss Cellular Immunotherapy's Potential Role in Treat
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
09:20am, Tuesday, 12'th Mar 2024
Keynote Will Discuss Cellular Immunotherapy's Potential for Treating Chronic Conditions, Including Cancer, Multiple Sclerosis and Parkinson's Disease Keynote Will Discuss Cellular Immunotherapy's Pote
Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells
09:35am, Thursday, 07'th Mar 2024
Company presenting an in vivo study of PT-CD16, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells at AACR Annual Meeting 2024 Company presenting an
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
08:53pm, Tuesday, 11'th Jul 2023
Best biotech stocks represents a concept that, no matter what, the market cycle fundamentally delivers relevance. Now, let me back up by stating that no individual company offers a guarantee of succes
Best Penny Stocks Today? 4 With Big News To Watch This Week
03:33pm, Monday, 22'nd May 2023
I'm sure if you're on this site, you're looking for info on the best penny stocks today. That means researching trends, analyzing data, and reading up on the latest news to formulate a thesis.
New Strong Buy Stocks for April 12th
09:54am, Wednesday, 12'th Apr 2023
CELU, MGI, LRMR, EQRX and SRZN have been added to the Zacks Rank #1 (Strong Buy) List on April 12, 2023.
Penny Stocks To Buy? 4 To Watch Now After Big News This Week
12:52pm, Monday, 03'rd Apr 2023
Penny stocks to watch with news this week. Are they a buy now or should you avoid them entirely?
Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It
10:44am, Friday, 17'th Mar 2023
Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search Celularity, Inc. (CELU): Here is What You Need to Know
10:32am, Monday, 06'th Mar 2023
Celularity, Inc. (CELU) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here is What to Know Beyond Why Celularity, Inc. (CELU) is a Trending Stock
10:32am, Monday, 20'th Feb 2023
Recently, Zacks.com users have been paying close attention to Celularity, Inc. (CELU). This makes it worthwhile to examine what the stock has in store.
Celularity, Inc. (CELU) is Attracting Investor Attention: Here is What You Should Know
10:32am, Wednesday, 08'th Feb 2023
Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 24'th Jan 2023
Zacks.com users have recently been watching Celularity, Inc. (CELU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors Heavily Search Celularity, Inc. (CELU): Here is What You Need to Know
10:32am, Wednesday, 11'th Jan 2023
Zacks.com users have recently been watching Celularity, Inc. (CELU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
After Plunging -38.63% in 4 Weeks, Here's Why the Trend Might Reverse for Celularity, Inc. (CELU)
11:17am, Monday, 09'th Jan 2023
Celularity, Inc. (CELU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in r
